CD38 and Miyoshi myopathy: First, ADO is produced in the BM niches where MM cells grow; second, ADO predominantly derives from the non-canonical pathway mediated by CD38/CD203a/CD73; third, disease severity is directly correlated with ADO levels, which are higher in patients with more severe prognoses.